GlaxoSmithKline (GSK) Using Collaborations To Build China Neuroscience R&D

10/11/2016 9:07:06 AM GlaxoSmithKline plans to strengthen its China R&D efforts, using collaborations to develop new neurological treatments. The research update came from GSK’s Min Li, PhD, who holds the dual titles of Global Head of Neurosciences and General Manager of R&D China. Established in 2007, GSK’s Shanghai R&D Center focuses on neurology. “In the field of neurological diseases, we are very much committed to neurodegeneration and neuroexcitation,” said Dr. Li. So far, GSK has established partnerships with scientists at four China universities. Please enable JavaScript to view the comments powered by Disqus. comments powered by


Link to Full Article: GlaxoSmithKline (GSK) Using Collaborations To Build China Neuroscience R&D

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!